---
input_text: Stem-cell gene therapy for the Wiskott-Aldrich syndrome.The Wiskott-Aldrich
  syndrome (WAS) is an X-linked recessive primary immunodeficiency disorder associated
  with thrombocytopenia, eczema, and autoimmunity. We treated two patients who had
  this disorder with a transfusion of autologous, genetically modified hematopoietic
  stem cells (HSC). We found sustained expression of WAS protein expression in HSC,
  lymphoid and myeloid cells, and platelets after gene therapy. T and B cells, natural
  killer (NK) cells, and monocytes were functionally corrected. After treatment, the
  patients' clinical condition markedly improved, with resolution of hemorrhagic diathesis,
  eczema, autoimmunity, and predisposition to severe infection. Comprehensive insertion-site
  analysis showed vector integration that targeted multiple genes controlling growth
  and immunologic responses in a persistently polyclonal hematopoiesis. (Funded by
  Deutsche Forschungsgemeinschaft and others; German Clinical Trials Register number,
  DRKS00000330.).
raw_completion_output: |-
  primary_disease: Wiskott-Aldrich syndrome

  medical_actions: transfusion of autologously genetically modified hematopoietic stem cells

  symptoms: thrombocytopenia; eczema; autoimmunity; hemorrhagic diathesis; predisposition to severe infection

  chemicals: 

  action_annotation_relationships: transfusion of autologously genetically modified hematopoietic stem cells TREATS thrombocytopenia IN Wiskott-Aldrich syndrome; transfusion of autologously genetically modified hematopoietic stem cells TREATS eczema IN Wiskott-Aldrich syndrome; transfusion of autologously genetically modified hematopoietic stem cells TREATS autoimmunity IN Wiskott-Aldrich syndrome; transfusion of autologously genetically modified hematopoietic stem cells TREATS hemorrhagic diathesis IN Wiskott-Aldrich syndrome; transfusion of autologously genetically modified hematopoietic stem cells PREVENTS predisposition to severe infection IN Wiskott-Aldrich syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  transfusion of autologously genetically modified hematopoietic stem cells PREVENTS predisposition to severe infection IN Wiskott-Aldrich syndrome

  ===

extracted_object:
  primary_disease: MONDO:0010518
  medical_actions:
    - transfusion of autologously genetically modified hematopoietic stem cells
  symptoms:
    - HP:0001873
    - HP:0000964
    - HP:0002960
    - HP:0001892
    - predisposition to severe infection
  action_annotation_relationships:
    - subject: MAXO:0000756
      predicate: TREATS
      object: HP:0001873
      qualifier: MONDO:0010518
      subject_extension: autologously genetically modified hematopoietic stem cells
    - subject: <transfusion>
      predicate: <TREATS>
      object: <eczema>
      qualifier: <Wiskott-Aldrich syndrome>
      subject_extension: <autologously genetically modified hematopoietic stem cells>
    - subject: MAXO:0000756
      predicate: TREATS
      object: HP:0002960
      qualifier: MONDO:0010518
      subject_extension: autologously genetically modified hematopoietic stem cells
    - subject: MAXO:0000756
      predicate: TREATS
      object: HP:0001892
      qualifier: MONDO:0010518
      subject_extension: autologously genetically modified hematopoietic stem cells
    - subject: MAXO:0000756
      predicate: PREVENTS
      object: predisposition to severe infection
      qualifier: MONDO:0010518
      object_qualifier: severe
      subject_extension: autologously genetically modified hematopoietic stem cells
named_entities:
  - id: MONDO:0008891
    label: Brown-Vialetto-Van Laere syndrome
  - id: MAXO:0009004
    label: exome sequencing
  - id: HP:0000407
    label: sensorineural hearing loss
  - id: HP:0002093
    label: respiratory insufficiency
  - id: HP:0010871
    label: sensory ataxia
  - id: HP:0000648
    label: optic atrophy
  - id: CHEBI:17015
    label: riboflavin
  - id: HP:0012469
    label: infantile spasms
  - id: HP:0000789
    label: infertility
  - id: HP:0005268
    label: miscarriage
  - id: CHEBI:16709
    label: pyridoxine
  - id: CHEBI:18405
    label: pyridoxal 5'-phosphate
  - id: CHEBI:27306
    label: vitamin B6
  - id: CHEBI:24041
    label: flavin mononucleotide
  - id: HP:0001250
    label: seizures
  - id: MONDO:0009974
    label: Familial hemophagocytic lymphohistiocytosis
  - id: MAXO:0010030
    label: bone marrow transplantation (BMT)
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: CHEBI:4911
    label: etoposide
  - id: MAXO:0000757
    label: infusion
  - id: CHEBI:41264
    label: busulfan (BU), cyclophosphamide (CP), etoposide (VP16), antithymocyte globulin
      (ATG)
  - id: MAXO:0000750
    label: conditioning regimen
  - id: CHEBI:73896
    label: gene therapy (GT)
  - id: MONDO:0009666
    label: Holocarboxylase synthetase deficiency
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0001942
    label: Metabolic acidosis
  - id: CHEBI:15956
    label: Biotin
  - id: HP:0003256
    label: Coagulopathy
  - id: CHEBI:48669
    label: Tranexamic acid
  - id: CHEBI:48675
    label: antifibrinolytic agents
  - id: MONDO:0020300
    label: Autosomal dominant nocturnal frontal lobe epilepsy
  - id: CHEBI:3387
    label: Carbamazepine
  - id: MONDO:0000903
    label: Myoclonus-dystonia
  - id: MAXO:0000943
    label: Deep Brain Stimulation
  - id: HP:0001252
    label: Hypotonia
  - id: MONDO:0005338
    label: Primary open-angle glaucoma (POAG)
  - id: MAXO:0001082
    label: Trabeculectomy
  - id: MAXO:0000960
    label: Viscocanalostomy
  - id: HP:0007906
    label: Elevated intraocular pressure (IOP)
  - id: HP:0000253
    label: Progressive microcephaly
  - id: HP:0001263
    label: Global developmental delay
  - id: HP:0000365
    label: Hearing loss
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:15681
    label: GM3
  - id: CHEBI:28892
    label: Ganglioside
  - id: MAXO:0001298
    label: therapies
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:8378
    label: Prednisolone
  - id: MONDO:0015626
    label: Charcot-Marie-Tooth disease (CMT)
  - id: MAXO:0035087
    label: peripheral nerve biopsy
  - id: HP:0011096
    label: demyelination
  - id: HP:0001605
    label: vocal cord paralysis
  - id: MONDO:0007947
    label: Marfan's syndrome
  - id: HP:0001659
    label: aortic regurgitation
  - id: CHEBI:2904
    label: atenolol
  - id: CHEBI:6541
    label: losartan
  - id: MONDO:0004691
    label: Autosomal dominant polycystic kidney disease (ADPKD)
  - id: MAXO:0000004
    label: surgery
  - id: HP:0002586
    label: peritonitis
  - id: HP:0100543
    label: cognitive impairment
  - id: HP:0003546
    label: exercise intolerance
  - id: HP:0001332
    label: dystonia
  - id: HP:0001336
    label: myoclonus
  - id: HP:0001272
    label: cerebellar atrophy
  - id: HP:0002059
    label: cerebral atrophy
  - id: CHEBI:46245
    label: coenzyme Q10 (CoQ10)
  - id: MONDO:0009693
    label: multiple myeloma
  - id: HP:0002720
    label: IgA deficiency
  - id: HP:0006775
    label: multiple myeloma
  - id: MONDO:0011787
    label: Limb-girdle muscular dystrophy type 2I (LGMD2I)
  - id: MONDO:0009662
    label: Sly disease (mucopolysaccharidosis VII)
  - id: HP:0002321
    label: vertigo
  - id: HP:0040268
    label: recurrent infections of the middle ears
  - id: MONDO:0100137
    label: Telomere Diseases
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0001394
    label: Liver cirrhosis
  - id: HP:0002206
    label: Pulmonary fibrosis
  - id: HP:0003394
    label: Muscle cramps
  - id: CHEBI:4315
    label: Danazol
  - id: MONDO:0015286
    label: complete DiGeorge syndrome (cDGS)
  - id: MAXO:0010042
    label: Thymus transplantation
  - id: HP:0001973
    label: Autoimmune thrombocytopenia
  - id: HP:0100646
    label: Thyroiditis
  - id: HP:0001875
    label: Neutropenia
  - id: HP:0012378
    label: fatigue
  - id: MONDO:0010421
    label: X-linked Agammaglobulinemia
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0007765
    label: Hyperostosis cranialis interna
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: HP:0004322
    label: short stature
  - id: MONDO:0015168
    label: arthrogryposis multiplex congenita
  - id: HP:0002828
    label: multiple joint contractures
  - id: HP:0034392
    label: joint contractures
  - id: MONDO:0010518
    label: Wiskott-Aldrich syndrome (WAS)
  - id: MAXO:0001077
    label: splenectomy
  - id: HP:0001873
    label: thrombocytopenia
  - id: MONDO:0011724
    label: Glut-1 deficiency syndrome
  - id: HP:0005484
    label: acquired microcephaly
  - id: HP:0001257
    label: spasticity
  - id: HP:0001251
    label: ataxia
  - id: HP:0011972
    label: hypoglycorrhachia
  - id: MONDO:0000188
    label: GLUT1 deficiency syndrome
  - id: HP:0001508
    label: Failure to thrive
  - id: HP:0000787
    label: Renal stones
  - id: CHEBI:37054
    label: 3-hydroxybutyrate
  - id: MONDO:0019353
    label: Stargardt disease
  - id: MONDO:0015974
    label: Severe combined immunodeficiency (SCID)
  - id: HP:0000964
    label: eczema
  - id: HP:0002960
    label: autoimmunity
  - id: HP:0001892
    label: hemorrhagic diathesis
  - id: MAXO:0000756
    label: transfusion
